Turner MedTech will exhibit its contract manufacturing capabilities at the 2025 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit, demonstrating the state's robust medical technology innovation landscape. The company will showcase partnerships with KyphoLift and PollenSense, presenting cutting-edge solutions in medical device manufacturing and technology.
The summit, taking place March 13-14 in Salt Lake City, represents a significant opportunity for medtech companies to highlight breakthrough technologies. KyphoLift will present its innovative MRI device designed to improve patient positioning and imaging accuracy for individuals with spinal conditions. The device addresses critical challenges in patient comfort and diagnostic precision during medical imaging procedures.
PollenSense will also be featured, introducing advanced automated sensors that provide real-time pollen and mold monitoring. This technology represents a substantial advancement in environmental health monitoring, offering hyperlocal data that can help individuals proactively manage allergies and respiratory conditions.
Utah's life sciences sector continues to demonstrate remarkable growth, contributing $22.6 billion to the state's GDP and supporting approximately 180,000 jobs. The summit underscores the region's commitment to fostering technological innovation and entrepreneurship in medical technology.
Turner MedTech's participation highlights the company's expertise in contract manufacturing, including design support, rapid prototyping, and commercialization services. By showcasing these capabilities, the company reinforces its position as a key player in medical device development and production.
